Table 2.
Coef (B) | 95% CI | p | ||
---|---|---|---|---|
Lower Limit | Upper Limit | |||
Augmentation Strategy | −0.02 | −0.88 | 0.46 | 0.54 |
Sessions per day | 0.49 | −0.18 | 1.18 | 0.15 |
Session duration | −0.27 | −0.09 | 0.41 | 0.43 |
Number of weeks | −0.05 | −0.16 | 0.48 | 0.27 |
Session total | −0.03 | −0.08 | 0.01 | 0.18 |
Note: Meta-regressions were performed using one variable per time due to the relatively low sample size included in this meta-analysis. Statistical significance was indicated by p ≤ 0.05. Therefore, no variable was found to be statistically significant. Augmentation strategy: tDCS combined with concurrently commenced other interventions (i.e., pharmacotherapy). Abbreviation: CI—confidence interval.